The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Open accessAbstract
Background & aims Norfloxacin is highly effective in preventing spontaneous bacterial peritonitis recurrence in cirrhosis, but its role in the primary prevention of this complication is uncertain.Methods Patients with cirrhosis and low protein ascitic levels (<15 g/L) with advanced liver failure (Child-Pugh score > or = 9 points with serum bilirubin level > or = 3 mg/dL) or impaired renal function (serum creatinine level > or = 1.2 mg/dL, blood urea nitrogen level > or = 25 mg/dL, or serum sodium level < or = 130 mEq/L) were included in a randomized controlled trial aimed at comparing norfloxacin (35 patients) vs placebo (33 patients) in the primary prophylaxis of spontaneous bacterial peritonitis. The main end points of the trial were 3-month and 1-year probability of survival. Secondary end points were 1-year probability of development of spontaneous bacterial peritonitis and hepatorenal syndrome.Results Norfloxacin administration reduced the 1-year probability of developing spontaneous bacterial peritonitis (7% vs 61%, P < .001) and hepatorenal syndrome (28% vs 41%, P = .02), and improved the 3-month (94% vs 62%, P = .003) and the 1-year (60% vs 48%, P = .05) probability of survival compared with placebo.Conclusions Primary prophylaxis with norfloxacin has a great impact in the clinical course of patients with advanced cirrhosis. It reduces the incidence of spontaneous bacterial peritonitis, delays the development of hepatorenal syndrome, and improves survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to norfloxacin, rifaximin has been noted to increased survival in patients with advanced liver cirrhosis in several small-scale trials92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Moreover, several small-scale clinical studies have suggested that antibiotics such as norfloxacin and rifaximin increase survival in patients with liver cirrhosis92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
Arroyo, V., Ginès, P., Gerbes, A. L., Dudley, F. J., Geñtilini, P., Laffi, G., Reynolds, T. B., Ring‐Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,694
Self-citationSort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruíz-del-Árbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410603 · Cited by 1,636
Self-citationDiagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
Rimola, A., García–Tsao, G., Navasa, M., Piddock, L. J. V., Planas, R., Bernard‐Chabert, B., & Inadomi, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80201-9 · Cited by 1,058
Self-citationFernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Self-citationIncidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginés, À., Escorsell, À., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 874
Self-citationGinés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Self-citationFollo, A., Llovet, J. M., Navasa, M., Planas, R., Forns, X., Francitorra, A., Rimola, A., Gassull, M. A., Arroyo, V., & Rodés, J. (1994) · Hepatology · doi:10.1002/hep.1840200619 · Cited by 597
Self-citationCirculatory function and hepatorenal syndrome in cirrhosis†
Ruíz-del-Árbol, L., Monescillo, A., Arocena, C., Valer, P., Ginès, P., Moreira, V., Milicua, J. M., Jiménez, W., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20766 · Cited by 584
Self-citationRuíz-del-Árbol, L., Urmán, J., Fernández, J., González, M., Navasa, M., Monescillo, A., Albillos, A., Jiménez, W., & Arroyo, V. (2003) · Hepatology · doi:10.1053/jhep.2003.50447 · Cited by 496
Self-citationLlach, J., Ginès, P., Arroyo, V., Rimola, A., Titó, L., Badalamenti, S., Jiménez, W., Gaya, J., Rivera, F., & Rodés, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90441-6 · Cited by 457
Self-citation
Flagged first, then by citations
2 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 709
Renal failure in cirrhosis: Emerging concepts
Bittencourt, P. L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i21.2336 · Cited by 20
Optimal management of cirrhotic ascites: A review for internal medicine physicians
Gallo, A., Dedionigi, C., Civitelli, C., Panzeri, A., Corradi, C., & Squizzato, A. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0035 · Cited by 22
Management of HCV-related end-stage liver disease in HIV-coinfected patients.
Merchante, N., Jiménez‐Sáenz, M., & Pineda, J. A. (2007) · PubMed · Cited by 20
Bacterial Infections in Cirrhosis
Tonon, M., Angeli, P., & Piano, S. S. (2021) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000065 · Cited by 19
Emergency medicine updates: Spontaneous bacterial peritonitis
Long, B., & Gottlieb, M. A. (2023) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2023.05.015 · Cited by 19
Bacterial translocation aggravates CCl4-induced liver cirrhosis by regulating CD4+ T cells in rats
Shi, H., Lv, L., Cao, H., Lu, H., Zhou, N., Yang, J., Jiang, H., Dong, H., Hu, X., Yu, W., et al. (2017) · Scientific Reports · doi:10.1038/srep40516 · Cited by 19
Updates on Hepato-Renal Syndrome
Lee, K. F. H. T. (2013) · Journal of Anesthesia & Clinical Research · doi:10.4172/2155-6148.1000352 · Cited by 19
Acute kidney injury in patients with chronic liver disease
Rognant, N. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i7.993 · Cited by 19
Thévenot, T., Briot, C., Mace, V., Lison, H., Elkrief, L., Heurgué–Berlot, A., Bureau, C., Jézequel, C., Riachi, G., Louvet, A., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.344 · Cited by 19
Alotaibi, A., Almaghrabi, M., Ahmed, O., Rodrigues, D., Iansavitchene, A., Puka, K., Gandhi, R., Sey, M. S. L., Patel, K., & Brahmania, M. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002279 · Cited by 18
Tergast, T. L., Griemsmann, M., Stockhoff, L., Heidrich, B., Schirmer, H., Lenzen, H., Wedemeyer, H. H., Cornberg, M., Jaeckel, E., & Maasoumy, B. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17066 · Cited by 18
Khorsand, B., Rajabnia, M., Jahanian, A., Fathy, M., Taghvaei, S., & Houri, H. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.10.001 · Cited by 20
Bacterial infections in cirrhosis
Botwin, G. J., & Morgan, T. R. M. (2014) · Hepatology International · doi:10.1007/s12072-014-9522-z · Cited by 18
Emergencies of the Liver, Gallbladder, and Pancreas
Privette, T. W., Carlisle, M., & Palma, J. K. (2011) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2011.01.008 · Cited by 18
and the INCA trial group, Casper, M., Mengel, M., Fuhrmann, C., Herrmann, E. M., Appenrodt, B., Schiedermaier, P., Reichert, M., Bruns, T., Engelmann, C., et al. (2015) · Trials · doi:10.1186/s13063-015-0594-4 · Cited by 18
Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis.
Kaltsa, G., Bamias, G., Siakavellas, S. I., Goukos, D., Karagiannakis, D., Zampeli, E., Vlachogiannakos, J., Michopoulos, S., Vafiadi, I., Daikos, G. L., et al. (2016) · Europe PMC (PubMed Central) · Cited by 18
Guevara, M., & Arroyo, V. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.561200 · Cited by 18
Self-citationFactors affecting mortality and resource use for hospitalized patients with cirrhosis
Charatcharoenwitthaya, P., Soonthornworasiri, N., Karaketklang, K., Poovorawan, K., Ngum, W. P., Chotiyaputta, W., Tanwandee, T., & Phaosawasdi, K. (2017) · Medicine · doi:10.1097/md.0000000000007782 · Cited by 18
Venkat, D., & Kk, V. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181e07751 · Cited by 18
Secondary peritonitis in cirrhosis: “Oil in fire”
Wiest, R., & Schöelmerich, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.022 · Cited by 18
Rubiano, A. M. R., Villarreal, A. F. D., de Zubiría-Maria, A., Pinto, R., Hoz, J. D. L., Pérez‐Riveros, E. D., Ardila, G., & Sierra-Arango, F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239834 · Cited by 17
Sun, D., Zheng, C., Liu, W., Poucke, S. V., Mao, Z., Shi, K., Wang, X., Wang, J., & Zheng, M. (2017) · Aging · doi:10.18632/aging.101161 · Cited by 17
Faust, N. W., Yamada, A., Haider, H., Komaki, Y., Komaki, F., Micić, D., & Sakuraba, A. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i5.239 · Cited by 18
Shah, N. S., Silva, R. G., Kowalski, A., Desai, C., & Lerma, E. V. (2016) · Disease-a-Month · doi:10.1016/j.disamonth.2016.05.009 · Cited by 17
A French national survey on the use of antibiotic prophylaxis in cirrhotic patients
Thévenot, T., Degand, T., Grelat, N., Elkrief, L., Christol, C., Moreau, R., Henrion, J., Cadranel, J., Sheppard, F., Bureau, C., et al. (2012) · Liver International · doi:10.1111/liv.12093 · Cited by 17
Peritonitis and Intraperitoneal Abscesses
Levison, M. E., & Bush, L. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00076-x · Cited by 17
Bacterial Infections in Acute on Chronic Liver Failure
Incicco, S., Angeli, P., & Piano, S. S. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.03.013 · Cited by 16
Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment
Badura, K., Frąk, W., Hajdys, J., Majchrowicz, G., Młynarska, E., Rysz, J., & Franczyk, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417469 · Cited by 18
Hepatorenal Syndrome in the Intensive Care Unit
Wadei, H. M., & Gonwa, T. A. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066611408692 · Cited by 16
Tapper, E. B., Bonder, A., & Cárdenas, A. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.12.006 · Cited by 16
Recent advances in the understanding and management of hepatorenal syndrome
Simbrunner, B., Trauner, M. A., Reiberger, T., & Mandorfer, M. (2021) · Faculty Reviews · doi:10.12703/r/10-48 · Cited by 16
How, J., Azar, M. M., & Meyer, J. P. (2015) · PubMed · Cited by 16
Treatment of Spontaneous Bacterial Peritonitis
Salerno, F., & Mura, V. L. (2015) · Digestive Diseases · doi:10.1159/000375358 · Cited by 15
End‐stage liver disease: Management of hepatorenal syndrome
Mauro, E., Garcia‐Olveira, L., & Gadano, A. C. (2021) · Liver International · doi:10.1111/liv.14866 · Cited by 15
Shamseya, M. M., & Madkour, M. A. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.09.002 · Cited by 15
Xu, D., Zhao, M., Song, Y., Song, J., Huang, Y., & Wang, J. (2014) · Hepatology International · doi:10.1007/s12072-014-9588-7 · Cited by 15
Rifaximin in hepatic encephalopathy: More than just a non-absorbable antibiotic?
Jalan, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.002 · Cited by 15
Renal Insufficiency in the Patient with Chronic Liver Disease
Bozanich, N. K., & Kwo, P. Y. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2014.09.003 · Cited by 15
Mirnejad, R., Jeddi, F., Kiani, J., & Khoobdel, M. (2011) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(11)60049-2 · Cited by 14
Wang, W., Yang, J., Liu, C., Song, P., Wang, W., Xu, H., & Xia, X. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001446 · Cited by 14
Management of end-stage liver disease in HIV/hepatitis C virus co-infection
Spengler, U. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834bc691 · Cited by 14
The impact of infections on delisting patients from the liver transplantation waiting list
Alferink, L. J. M., Oey, R. C., Hansen, B. E., Polak, W. G., van Buuren, H. R., de Man, R. A., Schurink, C. A. M., & Metselaar, H. J. (2017) · Transplant International · doi:10.1111/tri.12965 · Cited by 14
Renal Dysfunction in Patients with Chronic Liver Disease
Lee, J. W. (2009) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2009.7.2.42 · Cited by 16
Caro, E., Francés, R., Zapater, P., Pascual, S., Bellot, P., & Such, J. M. (2016) · Liver International · doi:10.1111/liv.13118 · Cited by 14
Self-citationHooper, D. C., & Strahilevitz, J. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00034-5 · Cited by 14
Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites
Simbrunner, B., Röthenbacher, A., Haslacher, H., Bauer, D. J. M., Chromy, D., Bucsics, T., Schwabl, P., Paternostro, R., Scheiner, B., Trauner, M. A., et al. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619843000 · Cited by 13
Komplikationen der Leberzirrhose
Wittenburg, H., Tennert, U., & Berg, T. (2011) · Der Internist · doi:10.1007/s00108-011-2853-0 · Cited by 13
Yoo, J., Park, M. Y., & Kim, S. G. (2023) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.22.264 · Cited by 12
Khan, R., Ravi, S., Chirapongsathorn, S., Jennings, W., Salameh, H. M., Russ, K. B., Skinner, M., Mudumbi, S. K., Simonetto, D. A., Kuo, Y., et al. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.02.027 · Cited by 12
Infections in Cirrhosis: A Guide for the Clinician
Campbell, K. A., Trivedi, H. D., & Chopra, S. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.01.015 · Cited by 12
Melcarne, L., Sopeña, J., Martínez-Cerezo, F. J., Vergara, M., Miquel, M., Sánchez‐Delgado, J., Dalmau, B., Machlab, S., Portilla, D., González-Padrón, Y., et al. (2017) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2017.4517/2016 · Cited by 12
Renal dysfunction in cirrhosis
Parke, C. Y., Martin, P. B., & Bunnapradist, S. (2015) · Clinical Liver Disease · doi:10.1002/cld.485 · Cited by 12
Ginès, P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.020 · Cited by 12
Self-citationChanging Options for Prevention and Treatment of Infections in Cirrhosis
Acevedo, J., Prado, V., & Fernández, J. (2014) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0017-8 · Cited by 11
Self-citationManagement of Refractory Ascites and Hepatorenal Syndrome
Sussman, A. N., & BOYER, T. D. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0156-6 · Cited by 11
Factors that predict recurrent spontaneous bacterial peritonitis in cirrhotic patients
Termsinsuk, P., & Auesomwang, C. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13457 · Cited by 11
Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
Crocombe, D., & O'Brien, A. J. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000228 · Cited by 12
Shariff, M. I. F., Tognarelli, J. M., Lewis, M. R., Want, E. J., Mohamed, F. E. Z. A., Ladep, N. G., Crossey, M. M. E., Khan, S. A., Jalan, R., Holmes, E. C., et al. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.07.205 · Cited by 11
The Morbidity and Mortality of Laparoscopic Appendectomy in Patients with Cirrhosis
Al-Azzawi, Y., Al-Abboodi, Y., Fasullo, M. J., & Najuib, T. (2018) · Clinical Medicine Insights Gastroenterology · doi:10.1177/1179552217746645 · Cited by 11
Hillert, A., Schultalbers, M., Tergast, T. L., Vonberg, R., Rademacher, J., Wedemeyer, H. H., Cornberg, M., Ziesing, S., Maasoumy, B., & zu Siederdissen, C. H. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01871-w · Cited by 10
Sasso, R., Yassine, A. A., & Deeb, L. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235621 · Cited by 11
Multidrug-Resistant Bacterial Infection in Patients with Cirrhosis. A Review
Sanchez, L. O., & Gustot, T. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00447-3 · Cited by 11
Béjar-Serrano, S., del Pozo, P., la Varga, M. F.-D., & Benlloch, S. (2019) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2019.03.010 · Cited by 11
What’s new in the treatment of ascites and spontaneous bacterial peritonitis
Cárdenas, A., & Ginès, P. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0003-1 · Cited by 11
Self-citationChanging flora of bacterial infections in patients with cirrhosis
Runyon, B. A. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02337.x · Cited by 11
Bert, F., Valla, D. C., Moreau, R., & Nicolas-Chanoine, M.-H. (2008) · Liver Transplantation · doi:10.1002/lt.21474 · Cited by 11
Macnaughtan, J., Mookerjee, R. P., der Merwe, V., & Jalan, R. (2017) · Scientific Reports · doi:10.1038/srep40157 · Cited by 10
Song, S., Yang, Y., Geng, C., Tang, Z., Wang, C., & Li, X. F. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08557-6 · Cited by 11
Leung, W., & Wong, F. S.-H. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.549126 · Cited by 10
Management of Multidrug-Resistant Infections in Cirrhosis
Gallaher, C., & Shawcross, D. L. (2022) · Seminars in Liver Disease · doi:10.1055/a-1765-0056 · Cited by 9
Buccheri, S., & Da, B. L. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.01.002 · Cited by 10
Segarra‐Newnham, M., & Henneman, A. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p317 · Cited by 10
Aspects of pathogenetic pharmacotherapy for portal hypertension in liver cirrhosis
Garbuzenko, D. V. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh2016888101-108 · Cited by 10
Yu, Y., Li, T., Hu, Y., Yang, W., Zhang, Y., Deng, R., & Jiang, M. (2016) · Fluid Phase Equilibria · doi:10.1016/j.fluid.2016.12.012 · Cited by 10
Infecciones por bacterias multirresistentes en pacientes cirróticos en un hospital terciario
Béjar-Serrano, S., del Pozo, P., la Varga, M. F.-D., & Benlloch, S. (2018) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2018.07.017 · Cited by 10
Natural History and Stages of Cirrhosis
D’Amico, G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0002-2_2 · Cited by 10
Management of Chronic Liver Failure Until Liver Transplantation
Arora, G., & Keeffe, E. B. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.03.006 · Cited by 10
Salerno, F., & Monti, V. (2014) · Hepatology · doi:10.1002/hep.27015 · Cited by 10
Antibiotic resistance in patients with liver cirrhosis: Prevalence and current approach to tackle
Liakina, V. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i31.7530 · Cited by 8
From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury
Allegretti, A. S., Patidar, K. R., Ma, A. T., & Cullaro, G. (2024) · Hepatology · doi:10.1097/hep.0000000000000790 · Cited by 13
Renal Insufficiency in Patients with Cirrhosis
Matchett, C. L., Simonetto, D. A., & Kamath, P. S. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.08.010 · Cited by 9
Kulkarni, A. V., Rakam, K., Avadhanam, M., Yogita, V. P., Rachakonda, C., Satyavadi, A., Zuberi, A. A., Reddy, S., Iyengar, S., Gupta, A., et al. (2023) · Cureus · doi:10.7759/cureus.47151 · Cited by 9
Wang, J., Niu, D., Li, X., Zhao, Y., Ye, E., Huang, J., Yue, S., Hou, X., & Wu, J. (2024) · Renal Failure · doi:10.1080/0886022x.2023.2298900 · Cited by 10
Therapeutic strategies and emergence of multiresistant bacterial strains
Salerno, F., & Cazzaniga, M. (2010) · Internal and Emergency Medicine · doi:10.1007/s11739-010-0447-9 · Cited by 9
Potential Preventability of Spontaneous Bacterial Peritonitis
Ngamruengphong, S., NUGENT, K. M., Rakvit, A., & Parupudi, S. V. J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1647-5 · Cited by 9
Infectious complications in patients with liver cirrhosis.
Preda, S., Trifan, A. V., Gîrleanu, I., Stanciu, C., & Cojocariu, C. (2014) · The Medical-Surgical Journal · Cited by 9
Khatana, S. A. M., & Goldberg, D. S. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.08.023 · Cited by 8
Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota
Méndez‐Sánchez, N., Coronel-Castillo, C. E., Córdova‐Gallardo, J., & Qi, X. (2023) · Antibiotics · doi:10.3390/antibiotics12101475 · Cited by 8
Csák, T., & Bernstein, D. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.01.013 · Cited by 8
SPONTANEOUS BACTERIAL PERITONITIS
Tutchenko, M. I., Rudyk, D. V., Besedinskyi, M. S., & Chub, S. L. (2024) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2024;12(2):221-228 · Cited by 8
Acute on chronic liver failure
Trebicka, J., Praktiknjo, M., Peiffer, K., Pascher, A., Schulz, M. S., & Uschner, F. E. (2025) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2024.0255 · Cited by 9
A Historical Overview of Spontaneous Bacterial Peritonitis: From Rare to Resistant
Haque, L., & García–Tsao, G. (2021) · Clinical Liver Disease · doi:10.1002/cld.1122 · Cited by 8
Mansour, A., El-Rahman, A. A., & Besheer, T. A. (2013) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2013.05.004 · Cited by 8
Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis: Benefit or Risk?
Gonzalez, S. A. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000208 · Cited by 8
Grewal, P., & Martin, P. B. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.02.006 · Cited by 8
Bacterial infections in cirrhosis
Papp, M., Farkas, A., Udvardy, M., & Tornai, I. (2007) · Orvosi Hetilap · doi:10.1556/oh.2007.27882 · Cited by 8
Peritonitis and Intraperitoneal Abscesses
Levison, M. E., & Bush, L. M. (2010) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-0-443-06839-3.00071-0 · Cited by 8
Ascites and Spontaneous Bacterial Peritonitis
Arroyo, V., & Fernández, J. (2017) · doi:10.1002/9781119251316.ch15 · Cited by 8
Self-citationInsights on clinical relevance of sarcopenia in patients with cirrhosis and sepsis
Ebadi, M., & Montaño‐Loza, A. J. (2018) · Liver International · doi:10.1111/liv.13720 · Cited by 8
Téllez-Ávila, F. I., Sifuentes‐Osornio, J., Barbero-Becerra, V. J., Franco-Guzmán, A. M., Ruiz‐Cordero, R., Alfaro-Lara, R., Hernández-Ramírez, Á., & Vargas-Vorácková, F. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30906-8 · Cited by 7
Metadata
- Authors
- Fernández, J., Navasa, M., Planas, R., Montoliu, S., Monfort, D., Soriano, G., Vila, C., Pardo, A., Quintero, E., Vargas, V., Such, J., Ginès, P., & Arroyo, V.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital de Sant Pau (ES)
- Hospital Del Mar (ES)
- Hospital Universitario de Canarias (ES)
- Corresponding author
- Navasa, Miquel
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 133
- Issue
- 3
- Pages
- 818-824
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2012746560
- Cited by
- 709
- References
- 36
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 23 · 2023: 37 · 2022: 28 · 2021: 43 · 2020: 39 · 2019: 42 · 2018: 42 · 2017: 37 · 2016: 34 · 2015: 55 · 2014: 48 · 2013: 31 · 2012: 46
- FWCI
- 30.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Keywords
- spontaneous bacterial peritonitis, primary prophylaxis, norfloxacin, hepatorenal syndrome, liver cirrhosis, survival, renal dysfunction, antibiotic prophylaxis
- MeSH terms
- Aged, Anti-Infective Agents, Double-Blind Method, Female, Hepatorenal Syndrome, Humans, Liver Cirrhosis, Male, Middle Aged, Norfloxacin, Peritonitis, Risk Factors, Survival Analysis, Antibiotic Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
